𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Recombinant interferon gamma in rheumatoid arthritis. A double-blind study comparing immuneron (recombinant interferon gamma) with placebo

✍ Scribed by E.M. Veys; H. Mielants; G. Verbruggen; J.P. Grosclaude; F. Luyten; W. Meier; W. Fiers; A.R. Galazka

Publisher
Elsevier Science
Year
1988
Tongue
English
Weight
81 KB
Volume
10
Category
Article
ISSN
0192-0561

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Results of a multicenter placebo-control
Results of a multicenter placebo-controlled double-blind randomized phase III clinical study of treatment of rheumatoid arthritis with recombinant interferon-gamma
✍ E. M. Lemmel; D. Brackertz; M. Franke; W. Gaus; P. W. Hartl; K. Machalke; H. Mie πŸ“‚ Article πŸ“… 1988 πŸ› Springer 🌐 English βš– 660 KB

In a multicenter placebo-controlled double-blind randomized clinical study, 91 patients with rheumatoid arthritis were given 28 days' treatment with recombinant interferon-gamma (50 micrograms daily for 20 days, then 50 micrograms each second day up to day 28, given by subcutaneous injection). The a

Results of a phase-II clinical trial on
Results of a phase-II clinical trial on treatment of rheumatoid arthritis with recombinant interferon-gamma
✍ E. M. Lemmel; M. Franke; W. Gaus; P. W. Hartl; P. H. Hofschneider; K. Miehlke; K πŸ“‚ Article πŸ“… 1987 πŸ› Springer 🌐 English βš– 552 KB

In an open, non-randomized clinical trial conducted at multiple centres, 49 patients with rheumatoid arthritis were treated with recombinant interferon-gamma for 20 days. The study was carried out in two sub-studies. In the first, the total daily dose of interferon-gamma was 50 micrograms; in the se